Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Neda Rasouli

Concepts (369)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Insulin Resistance
38
2024
1072
4.760
 Why?
Diabetes Mellitus, Type 2
34
2024
2094
3.730
 Why?
Metformin
18
2024
276
3.090
 Why?
Thiazolidinediones
20
2014
142
2.460
 Why?
Adipose Tissue
24
2016
539
2.300
 Why?
Prediabetic State
9
2023
219
2.290
 Why?
Insulin-Secreting Cells
7
2022
317
2.010
 Why?
Hypoglycemic Agents
30
2024
1012
1.960
 Why?
Sulfonylurea Compounds
5
2024
44
1.440
 Why?
Obesity
24
2019
2508
1.410
 Why?
Vitamin D Deficiency
2
2022
158
1.380
 Why?
Cholecalciferol
4
2022
47
1.260
 Why?
Blood Glucose
23
2024
1826
1.190
 Why?
Insulin
22
2024
2078
1.090
 Why?
Cholesterol, HDL
2
2018
183
1.050
 Why?
Triglycerides
3
2018
467
0.970
 Why?
Fenofibrate
2
2016
24
0.940
 Why?
Muscle, Skeletal
11
2016
1472
0.850
 Why?
Glucose Tolerance Test
14
2022
343
0.850
 Why?
Insulin Glargine
8
2024
73
0.810
 Why?
Metabolic Syndrome
3
2018
321
0.760
 Why?
Receptors, Ghrelin
1
2020
7
0.720
 Why?
Gastroparesis
1
2020
8
0.720
 Why?
Lipid Metabolism
5
2016
444
0.710
 Why?
PPAR gamma
8
2014
182
0.710
 Why?
Glucose
9
2024
896
0.670
 Why?
Hypoxia
2
2016
957
0.670
 Why?
Diabetic Neuropathies
1
2020
79
0.670
 Why?
Adipokines
2
2010
42
0.660
 Why?
Diabetes Mellitus
6
2020
900
0.650
 Why?
Middle Aged
47
2022
26733
0.640
 Why?
Vitamin D
8
2023
341
0.630
 Why?
Subcutaneous Fat
5
2014
70
0.610
 Why?
Adipocytes
11
2014
188
0.600
 Why?
Dietary Supplements
7
2022
460
0.570
 Why?
Hyperglycemia
5
2016
291
0.550
 Why?
Humans
80
2024
114655
0.540
 Why?
Remote Consultation
1
2016
42
0.510
 Why?
Macrophages
10
2014
1261
0.510
 Why?
Fibrosis
3
2023
453
0.500
 Why?
Fatty Acids
2
2016
381
0.490
 Why?
Inflammation
12
2016
2478
0.480
 Why?
Adult
43
2022
30543
0.480
 Why?
Vitamins
5
2023
151
0.470
 Why?
Liraglutide
5
2024
27
0.440
 Why?
Sitagliptin Phosphate
5
2024
30
0.440
 Why?
C-Peptide
3
2024
138
0.430
 Why?
Female
44
2022
59489
0.430
 Why?
Aged
25
2022
19069
0.420
 Why?
Male
43
2022
55580
0.420
 Why?
Nuclear Receptor Co-Repressor 1
1
2012
16
0.410
 Why?
SUMO-1 Protein
1
2012
19
0.400
 Why?
Glucose Intolerance
6
2010
136
0.380
 Why?
Lipids
2
2020
580
0.370
 Why?
Cohort Studies
7
2020
4895
0.370
 Why?
Patient Admission
1
2012
176
0.360
 Why?
Histone Deacetylases
1
2012
195
0.360
 Why?
Inpatients
2
2013
380
0.340
 Why?
Receptors, Scavenger
1
2009
16
0.330
 Why?
Gene Expression Regulation
6
2015
2319
0.330
 Why?
Body Mass Index
11
2021
1958
0.310
 Why?
Gene Expression
7
2010
1421
0.300
 Why?
Metabolic Diseases
1
2008
98
0.290
 Why?
Adipose Tissue, White
2
2019
27
0.280
 Why?
Choristoma
1
2007
23
0.270
 Why?
Dietary Fats
1
2008
287
0.260
 Why?
Muscles
3
2012
320
0.260
 Why?
Young Adult
11
2016
10466
0.240
 Why?
Gene Expression Regulation, Enzymologic
3
2013
270
0.230
 Why?
RNA, Messenger
11
2015
2552
0.230
 Why?
Cystic Fibrosis
1
2012
955
0.210
 Why?
Adiponectin
4
2009
213
0.210
 Why?
Islets of Langerhans
2
2005
726
0.200
 Why?
Dipeptidyl-Peptidase IV Inhibitors
2
2022
44
0.200
 Why?
Insulin, Long-Acting
2
2012
52
0.190
 Why?
Follow-Up Studies
2
2022
4411
0.190
 Why?
Treatment Outcome
7
2024
9088
0.190
 Why?
Ligands
3
2012
561
0.190
 Why?
Metoclopramide
1
2020
16
0.180
 Why?
Enteral Nutrition
2
2012
159
0.180
 Why?
Gastric Emptying
1
2020
40
0.180
 Why?
Quantitative Trait Loci
2
2012
305
0.180
 Why?
Glucosides
1
2020
36
0.180
 Why?
China
1
2020
161
0.170
 Why?
Benzhydryl Compounds
1
2020
60
0.170
 Why?
Atherosclerosis
2
2018
341
0.170
 Why?
Non-alcoholic Fatty Liver Disease
1
2023
245
0.170
 Why?
Cardiology
1
2022
259
0.170
 Why?
Cardiovascular Diseases
3
2022
1727
0.170
 Why?
Renal Insufficiency
1
2021
137
0.170
 Why?
Coculture Techniques
5
2011
201
0.160
 Why?
Linagliptin
1
2018
4
0.160
 Why?
Insulin, Short-Acting
1
2018
4
0.160
 Why?
Cross-Sectional Studies
4
2023
4407
0.160
 Why?
Gene Expression Profiling
4
2015
1518
0.160
 Why?
Adipose Tissue, Brown
1
2019
43
0.160
 Why?
Glomerular Filtration Rate
1
2021
604
0.150
 Why?
Incidence
2
2022
2312
0.150
 Why?
Overweight
1
2022
471
0.150
 Why?
Hyperoxia
1
2019
99
0.150
 Why?
Perioperative Care
1
2018
127
0.150
 Why?
Cells, Cultured
6
2016
3885
0.140
 Why?
Surgical Procedures, Operative
1
2018
207
0.130
 Why?
Endoplasmic Reticulum
2
2008
234
0.130
 Why?
Double-Blind Method
4
2022
1660
0.130
 Why?
Abdominal Fat
2
2006
39
0.130
 Why?
Medical Staff, Hospital
1
2016
75
0.130
 Why?
Body Weight
1
2020
870
0.130
 Why?
Arginine
2
2007
238
0.130
 Why?
Endocrinology
1
2016
70
0.130
 Why?
Hospitalization
4
2018
1750
0.120
 Why?
Adolescent
7
2016
17838
0.120
 Why?
Drug Therapy, Combination
3
2024
951
0.120
 Why?
Oxidation-Reduction
2
2016
923
0.120
 Why?
Cell Line
6
2010
2635
0.120
 Why?
Thermogenesis
1
2014
37
0.120
 Why?
Fish Oils
1
2014
21
0.120
 Why?
Scavenger Receptors, Class E
2
2015
2
0.120
 Why?
Area Under Curve
1
2015
274
0.110
 Why?
Adiposity
2
2010
457
0.110
 Why?
Palmitic Acid
3
2011
36
0.110
 Why?
ROC Curve
1
2015
442
0.110
 Why?
Acetyl-CoA Carboxylase
1
2013
33
0.110
 Why?
Medically Uninsured
1
2014
121
0.110
 Why?
Cardiomyopathies
2
2007
298
0.110
 Why?
Transcriptional Activation
1
2014
337
0.100
 Why?
Biopsy
3
2012
1036
0.100
 Why?
Muscle Fibers, Skeletal
2
2011
185
0.100
 Why?
Insulin Infusion Systems
2
2012
299
0.100
 Why?
Retrospective Studies
5
2016
12545
0.100
 Why?
RNA, Small Interfering
2
2012
535
0.100
 Why?
Randomized Controlled Trials as Topic
3
2023
1214
0.100
 Why?
Cytokines
4
2010
1840
0.100
 Why?
Seasons
1
2014
442
0.100
 Why?
PPAR alpha
1
2012
52
0.100
 Why?
Patient Preference
1
2014
167
0.100
 Why?
CD36 Antigens
2
2009
37
0.100
 Why?
Temperature
1
2014
565
0.100
 Why?
Biphasic Insulins
1
2011
3
0.100
 Why?
Patient Care Team
1
2016
517
0.100
 Why?
Risk Factors
6
2022
8631
0.100
 Why?
Insulin Lispro
1
2011
35
0.100
 Why?
Antigens, Differentiation, Myelomonocytic
3
2007
53
0.100
 Why?
Continuity of Patient Care
1
2014
253
0.100
 Why?
Hypolipidemic Agents
2
2018
86
0.100
 Why?
Docosahexaenoic Acids
1
2011
69
0.090
 Why?
Prognosis
1
2018
3327
0.090
 Why?
Receptors, Tumor Necrosis Factor
1
2011
140
0.090
 Why?
Collagen Type VI
1
2010
3
0.090
 Why?
Molecular Weight
2
2008
331
0.090
 Why?
Polymorphism, Single Nucleotide
3
2013
1879
0.090
 Why?
Lipase
1
2010
55
0.090
 Why?
Disease Models, Animal
2
2019
3531
0.090
 Why?
Comparative Effectiveness Research
2
2022
130
0.090
 Why?
Matrix Metalloproteinase Inhibitors
1
2010
13
0.090
 Why?
Body Composition
3
2011
590
0.090
 Why?
Adipogenesis
1
2010
42
0.090
 Why?
Lipogenesis
1
2010
56
0.090
 Why?
Diabetic Nephropathies
1
2013
234
0.090
 Why?
Predictive Value of Tests
1
2015
1796
0.090
 Why?
Bicycling
1
2010
86
0.090
 Why?
Medicaid
1
2014
406
0.080
 Why?
Logistic Models
1
2015
1840
0.080
 Why?
Quality of Life
1
2020
2353
0.080
 Why?
Scavenger Receptors, Class A
1
2009
9
0.080
 Why?
Reverse Transcriptase Polymerase Chain Reaction
5
2010
923
0.080
 Why?
Matrix Metalloproteinase 9
1
2010
119
0.080
 Why?
MicroRNAs
1
2015
600
0.080
 Why?
Heart Failure
1
2022
1945
0.080
 Why?
Antigens, CD
3
2007
442
0.080
 Why?
Myoblasts, Skeletal
1
2009
11
0.080
 Why?
Infant
2
2020
7959
0.080
 Why?
Chemokine CCL2
2
2007
105
0.080
 Why?
Myositis
1
2009
44
0.080
 Why?
Stress, Physiological
2
2008
378
0.080
 Why?
Dose-Response Relationship, Drug
4
2020
1842
0.080
 Why?
Stearoyl-CoA Desaturase
1
2008
53
0.080
 Why?
Fatty Acids, Nonesterified
1
2009
151
0.080
 Why?
Anti-Inflammatory Agents
1
2011
447
0.070
 Why?
Extracellular Matrix
1
2011
436
0.070
 Why?
Thrombospondin 1
1
2007
19
0.070
 Why?
Retinol-Binding Proteins
1
2007
13
0.070
 Why?
Animals
10
2019
31698
0.070
 Why?
TCF Transcription Factors
1
2007
20
0.070
 Why?
Administration, Oral
2
2020
728
0.070
 Why?
Child, Preschool
1
2020
9111
0.070
 Why?
Liver
3
2013
1637
0.070
 Why?
Adipocytes, White
2
2019
17
0.070
 Why?
Transcriptome
1
2012
725
0.070
 Why?
Peroxisome Proliferator-Activated Receptors
1
2006
14
0.070
 Why?
Down-Regulation
1
2009
594
0.070
 Why?
Diacylglycerol O-Acyltransferase
1
2006
3
0.070
 Why?
Cell Differentiation
2
2011
1700
0.070
 Why?
Fatty Acid Synthases
1
2006
23
0.070
 Why?
Quality Improvement
1
2014
950
0.070
 Why?
Lipoprotein Lipase
1
2006
54
0.070
 Why?
Genome-Wide Association Study
1
2012
1177
0.070
 Why?
Resistin
1
2005
12
0.060
 Why?
Niacin
1
2005
18
0.060
 Why?
Veterans
1
2016
1249
0.060
 Why?
Fructosamine
1
2004
14
0.060
 Why?
Genetic Predisposition to Disease
1
2013
2085
0.060
 Why?
Models, Biological
2
2008
1620
0.060
 Why?
Phenotype
1
2012
2796
0.060
 Why?
Tissue Distribution
1
2005
286
0.060
 Why?
Apolipoproteins E
1
2004
80
0.060
 Why?
Insulin, Regular, Human
1
2024
33
0.060
 Why?
Polymorphism, Genetic
1
2007
610
0.060
 Why?
Intracellular Signaling Peptides and Proteins
1
2006
386
0.060
 Why?
Leptin
1
2005
210
0.060
 Why?
Diabetes Complications
1
2006
211
0.060
 Why?
Diabetes Mellitus, Type 1
3
2014
3252
0.060
 Why?
Biomarkers
3
2008
3408
0.050
 Why?
Obesity, Morbid
1
2006
197
0.050
 Why?
Anti-Obesity Agents
2
2018
45
0.050
 Why?
Elastin
2
2014
78
0.050
 Why?
Diabetic Ketoacidosis
1
2004
159
0.050
 Why?
Nuclear Proteins
1
2006
591
0.050
 Why?
Glucagon-Like Peptide-1 Receptor
1
2022
72
0.050
 Why?
Child
1
2020
18407
0.050
 Why?
Arteriosclerosis
1
2002
83
0.050
 Why?
Apoptosis
2
2011
2362
0.050
 Why?
Liver Cirrhosis
1
2023
227
0.050
 Why?
Hypoglycemia
2
2018
386
0.050
 Why?
Angiotensin Receptor Antagonists
1
2021
76
0.050
 Why?
American Heart Association
1
2022
264
0.050
 Why?
Coronary Artery Disease
1
2007
607
0.050
 Why?
Albuminuria
1
2021
164
0.040
 Why?
Multicenter Studies as Topic
1
2021
249
0.040
 Why?
Angiotensin-Converting Enzyme Inhibitors
1
2021
179
0.040
 Why?
Receptors, Cytoplasmic and Nuclear
1
2002
192
0.040
 Why?
Consensus
1
2022
537
0.040
 Why?
Mice
7
2013
14863
0.040
 Why?
Oxidative Stress
1
2006
1076
0.040
 Why?
Creatinine
1
2021
425
0.040
 Why?
Calibration
1
2020
125
0.040
 Why?
Maximum Tolerated Dose
1
2020
183
0.040
 Why?
Tumor Necrosis Factor-alpha
1
2004
1139
0.040
 Why?
Adipocytes, Brown
1
2019
6
0.040
 Why?
Streptozocin
1
2019
16
0.040
 Why?
Health Status Indicators
1
2020
156
0.040
 Why?
Carbohydrate Metabolism
1
2019
48
0.040
 Why?
Gynecologic Surgical Procedures
1
2018
44
0.040
 Why?
Transcription Factors
2
2008
1528
0.040
 Why?
Fasting
1
2020
240
0.040
 Why?
Treatment Failure
1
2019
331
0.040
 Why?
Digestive System Surgical Procedures
1
2018
91
0.040
 Why?
Rats, Wistar
1
2019
368
0.040
 Why?
Urologic Surgical Procedures
1
2018
94
0.040
 Why?
Diabetes Mellitus, Experimental
1
2019
160
0.040
 Why?
Disease-Free Survival
1
2019
620
0.040
 Why?
Diet, High-Fat
1
2019
225
0.040
 Why?
Transfection
2
2010
866
0.030
 Why?
Kaplan-Meier Estimate
1
2019
811
0.030
 Why?
Reference Values
2
2008
743
0.030
 Why?
Blotting, Western
2
2010
1147
0.030
 Why?
Aged, 80 and over
2
2018
6345
0.030
 Why?
G(M2) Activator Protein
1
2015
1
0.030
 Why?
Orthopedic Procedures
1
2018
208
0.030
 Why?
Myosin Type V
1
2015
9
0.030
 Why?
Fibroblasts
2
2011
838
0.030
 Why?
ADAM Proteins
1
2015
58
0.030
 Why?
3T3 Cells
2
2006
140
0.030
 Why?
Weight Loss
1
2020
642
0.030
 Why?
Uncoupling Protein 1
1
2014
15
0.030
 Why?
Mice, Knockout
2
2013
2568
0.030
 Why?
Myosin Heavy Chains
1
2015
177
0.030
 Why?
Antihypertensive Agents
1
2018
429
0.030
 Why?
Cluster Analysis
1
2015
455
0.030
 Why?
Ion Channels
1
2014
123
0.030
 Why?
Genome, Human
1
2015
347
0.030
 Why?
Mast Cells
1
2014
116
0.030
 Why?
Oligonucleotide Array Sequence Analysis
1
2015
740
0.030
 Why?
Hypertension
1
2021
1056
0.030
 Why?
Mitochondrial Proteins
1
2014
219
0.030
 Why?
United States
2
2022
12180
0.030
 Why?
Demography
1
2013
260
0.020
 Why?
Injections, Subcutaneous
1
2012
134
0.020
 Why?
Nerve Tissue Proteins
1
2015
529
0.020
 Why?
Organ Specificity
1
2012
268
0.020
 Why?
TWEAK Receptor
1
2011
5
0.020
 Why?
Up-Regulation
1
2014
807
0.020
 Why?
Tripartite Motif Proteins
1
2011
30
0.020
 Why?
Platelet Endothelial Cell Adhesion Molecule-1
1
2011
57
0.020
 Why?
Capillaries
1
2011
91
0.020
 Why?
Genetic Association Studies
1
2013
339
0.020
 Why?
1-Acylglycerol-3-Phosphate O-Acyltransferase
1
2010
3
0.020
 Why?
Atrophy
1
2011
152
0.020
 Why?
Receptors, Adiponectin
1
2010
15
0.020
 Why?
Rats
1
2019
4958
0.020
 Why?
Ubiquitin-Protein Ligases
1
2011
139
0.020
 Why?
Protein Kinase C-alpha
1
2010
41
0.020
 Why?
Stromal Cells
1
2010
96
0.020
 Why?
Muscle Proteins
1
2011
210
0.020
 Why?
Energy Metabolism
1
2014
731
0.020
 Why?
Fluorescent Antibody Technique
1
2010
397
0.020
 Why?
Th1 Cells
1
2010
123
0.020
 Why?
Collagen
1
2011
415
0.020
 Why?
Pilot Projects
1
2014
1373
0.020
 Why?
Oligonucleotides
1
2010
137
0.020
 Why?
Waist-Hip Ratio
1
2008
30
0.020
 Why?
Patient Readmission
1
2014
610
0.020
 Why?
Regulatory Factor X Transcription Factors
1
2008
9
0.020
 Why?
X-Box Binding Protein 1
1
2008
7
0.020
 Why?
Mice, Obese
1
2008
53
0.020
 Why?
Centrifugation, Density Gradient
1
2008
40
0.020
 Why?
Activating Transcription Factor 6
1
2008
16
0.020
 Why?
eIF-2 Kinase
1
2008
24
0.020
 Why?
Transcription Factor CHOP
1
2008
28
0.020
 Why?
Chelating Agents
1
2008
65
0.020
 Why?
Oxygen Consumption
1
2010
588
0.020
 Why?
Endoribonucleases
1
2008
62
0.020
 Why?
Sucrose
1
2008
92
0.020
 Why?
Patient Discharge
1
2014
772
0.020
 Why?
Heat-Shock Proteins
1
2008
113
0.020
 Why?
Retinol-Binding Proteins, Plasma
1
2007
6
0.020
 Why?
Cell Fractionation
1
2007
51
0.020
 Why?
Indians, North American
1
2013
570
0.020
 Why?
Signal Transduction
2
2011
4512
0.020
 Why?
Cell Communication
1
2009
279
0.020
 Why?
Transcription Factor 7-Like 2 Protein
1
2007
24
0.020
 Why?
Glucose Transporter Type 4
1
2007
36
0.020
 Why?
Mice, Inbred C57BL
2
2006
4692
0.020
 Why?
Molecular Chaperones
1
2008
157
0.020
 Why?
Nicotinamide Phosphoribosyltransferase
1
2006
6
0.020
 Why?
Protein Isoforms
1
2008
338
0.020
 Why?
Phosphatidate Phosphatase
1
2006
5
0.020
 Why?
Blotting, Northern
1
2006
193
0.020
 Why?
Muscle Cells
1
2006
42
0.020
 Why?
Isomerism
1
2006
43
0.020
 Why?
Caspase 9
1
2006
48
0.020
 Why?
Diet, Carbohydrate-Restricted
1
2006
28
0.020
 Why?
Longitudinal Studies
1
2013
2387
0.020
 Why?
Phosphoproteins
1
2008
298
0.020
 Why?
In Situ Nick-End Labeling
1
2006
119
0.020
 Why?
Anilides
1
2006
67
0.020
 Why?
DNA Primers
1
2006
510
0.020
 Why?
Cell Culture Techniques
1
2007
342
0.020
 Why?
Caspase 3
1
2006
235
0.020
 Why?
Caspases
1
2006
245
0.020
 Why?
Cell Count
1
2005
303
0.010
 Why?
Genome
1
2006
271
0.010
 Why?
In Vitro Techniques
1
2006
1016
0.010
 Why?
Colorado
1
2014
4099
0.010
 Why?
Life Style
1
2006
430
0.010
 Why?
RNA
1
2010
809
0.010
 Why?
Genes, Reporter
1
2004
257
0.010
 Why?
Homeostasis
1
2007
573
0.010
 Why?
Enhancer Elements, Genetic
1
2004
151
0.010
 Why?
Stem Cells
1
2007
545
0.010
 Why?
Reactive Oxygen Species
1
2006
531
0.010
 Why?
Base Sequence
1
2006
2114
0.010
 Why?
Amino Acid Sequence
1
2006
1982
0.010
 Why?
Peptide Fragments
1
2006
666
0.010
 Why?
Calcium
1
2008
1108
0.010
 Why?
Genotype
1
2007
1760
0.010
 Why?
Antioxidants
1
2006
530
0.010
 Why?
Immunohistochemistry
1
2006
1629
0.010
 Why?
Molecular Sequence Data
1
2006
2785
0.010
 Why?
Myocardium
1
2006
913
0.010
 Why?
DNA-Binding Proteins
1
2008
1314
0.010
 Why?
Muscle, Smooth
1
2002
144
0.010
 Why?
Prospective Studies
1
2012
6217
0.010
 Why?
Morbidity
1
2002
280
0.010
 Why?
Mitochondria
1
2006
747
0.010
 Why?
Cardiovascular System
1
2002
125
0.010
 Why?
Blood Coagulation
1
2002
218
0.010
 Why?
Promoter Regions, Genetic
1
2004
1131
0.010
 Why?
Mortality
1
2002
287
0.010
 Why?
Rasouli's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (369) concept(s)
_
Co-Authors Expand Description
See all (15) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)